MacroGenics Inc. share price logo

MacroGenics Inc.

NASDAQ: MGNX

Small Cap

$3.70

-0.31

(-7.73%)

as on

MacroGenics Inc. Stock Performance

as on July 25, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $3.36
    $4.05
    downward going graph

    9.19%

    Downside

    9.46%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.29
    $5.08
    downward going graph

    65.14%

    Downside

    37.30%

    Upside

    downward going graph

MacroGenics Inc. share price movements today

Previous Close
$4.01
Open
$4.05
Volume
3.1M
Day's Low - High
$3.36 - $4.05
52 Week Low - High
$1.29 - $5.08

MacroGenics Inc. Historical Returns

1 Month Return
-23.08 %
3 Month Return
+ 15.99 %
1 Year Return
+ 116.37 %
3 Year Return
-21.11 %
5 Year Return
-85.45 %

MacroGenics Inc. Stock Fundamentals & Key Indicators

Check MacroGenics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$254.9M

EPS (TTM)

0.035

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.70%

PE Ratio (TTM)

0

PEG Ratio

0.01

EBITDA

-56.6M

Revenue (TTM)

157.1M

Profit Margin

-44.79%

Return On Equity TTM

-140.27%

MacroGenics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MacroGenics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
MacroGenics Inc. image
MacroGenics Inc.
BUY$254.9M-85.45%NA-44.79%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$40.1B576.3%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$120.1B139.96%28.0135.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$68.3B13.54%15.929.65%0.5499999999999999%

Stock Returns calculator for MacroGenics Inc. Stock including INR - Dollar returns

The MacroGenics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

MacroGenics Inc. investment value today

Current value as on today

₹2,41,532

Returns

₹1,41,532

(+141.53%)

Returns from MacroGenics Inc. Stock

₹1,16,374 (+116.37%)

Dollar Impact

₹25,157 (+25.16%)

Analyst Recommendation on MacroGenics Inc. Stock

Based on 18 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for MacroGenics Inc.. Average target price of $6.75

MacroGenics Inc. Share Price Target

Get share price movements and forecasts by analysts on MacroGenics Inc..

What analysts predicted

45.19%UPSIDE

Target Price

$6.75

Current Price

$3.7

Analyzed by

18 Analysts

Target

$6.75

MacroGenics Inc. target price $6.75, a slight upside of 45.19% compared to current price of $3.7. According to 18 analysts rating.

Indian Investors' Interest in MacroGenics Inc. Stock

Search interest for MacroGenics Inc. Stock has increased by 72% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:72% versus previous 30 day period

MacroGenics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
10
9
10
110
17
13
22
72
41
20
Gross Profit
-36
6
7
68
12
6
11
59
29
9
Operating Income
-49
-53
-58
54
-52
-42
-36
18
-12
-33
EBITDA
-44
-49
-53
58
-12
-39
-33
21
-8
-30
Interest Expense
2
1
0
-
0
0
0
3
4
4
Depreciation
1
1
1
1
2
1
1
1
1
1
Income Before Tax
-46
-52
-55
56
-14
-41
-36
16
-14
-36
Income Tax Expense
3
1
-
-1
0
-
0
-
0
-
Net Income
-46
-52
-55
56
-15
-41
-36
16
-14
-36
Net Profit Margin
-429.78%
-573.26%
-515.55%
50.86%
-86.98%
-311.07%
-162.99%
23.09%
-34.33%
-177.01%

MacroGenics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
86
155
60
62
97
75
151
57
148
149
Gross Profit
86
155
60
62
97
72
144
48
136
106
Operating Income
-60
-22
-171
-177
-131
-202
-121
-168
-110
-72
EBITDA
-52
-14
-162
-164
-119
-191
-109
2
-57
-59
Interest Expense
-
-
-
-
-
0
0
1
1
8
Depreciation
-
7
8
10
11
11
11
9
7
7
Income Before Tax
-58
-19
-171
-151
-129
-202
-119
-9
-66
-75
Income Tax Expense
-7
-7
0
10
-11
-11
0
9
0
0
Net Income
-58
-19
-171
-151
-117
-190
-120
-9
-66
-74
Net Profit Margin
-67.60%
-12.62%
-285.18%
-244.76%
-120.48%
-252.31%
-78.99%
-15.84%
-45.14%
-49.91%

MacroGenics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-52
-55
56
-15
-41
-36
16
-14
-36
Operating Cash Flow
-45
-44
60
-38
-46
-46
-30
43
-35
Investing Cash Flow
24
47
35
41
9
-37
-20
-65
45
Financing Cash Flow
0
0
0
0
0
69
-
0
0
Change in Cash
-20
3
95
3
-37
-14
-50
-22
9

MacroGenics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-19
-171
-151
-129
-202
-119
-9
-66
-74
Operating Cash Flow
14
-153
-134
-111
-143
-86
-78
-68
-81
Investing Cash Flow
77
56
-79
-7
-36
70
-80
149
-114
Financing Cash Flow
35
104
119
174
122
1
150
0
69
Change in Cash
127
8
-93
54
-57
-14
-7
81
-125

Global Institutional Holdings in MacroGenics Inc.

Funds
Holdings
Jane Street Group LLC
0.96%
Marshall Wace Asset Management Ltd
3.19%
JPMorgan Chase & Co
2.38%
Two Sigma Investments LLC
3.98%
Wasatch Advisors LP
3.18%
See all

Insights on MacroGenics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 399.2% return, outperforming this stock by 282.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 647.6% return, outperforming this stock by 668.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 16.82M → -36.77M (in $), with an average decrease of 172.0% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 72.83M → 20.77M (in $), with an average decrease of 46.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MGNX stock has moved down by -17.6%

About MacroGenics Inc.

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule that targets an undisclosed antigen expressed across several solid tumors, which is in preclinical trials. It is also developing T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
OrganisationMacroGenics Inc.
Headquarters9704 Medical Center Drive, Rockville, MD, United States, 20850
IndustryBiotechnology
CEOMr. Eric Blasius Risser
E-voting on sharesClick here to vote

Key Management of MacroGenics Inc.

Name

Title

Mr. Steve Harig

Senior Vice President of Human Resources

Ms. Beth Smith

VP, Controller & Treasurer

Mr. Eric Blasius Risser

CEO, President & Director

Mr. James Karrels

Senior VP & CFO

Dr. Ezio Bonvini M.D.

Senior VP of Research & Chief Scientific Officer

Dr. Frank George Perabo FEBU, M.D., Ph.D.

Vice President & Interim Head of Clinical Development

Dr. Thomas M. Spitznagel Ph.D.

Senior Vice President of Technical Operations

Mr. Jeffrey Stuart Peters J.D.

Senior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer

Mr. Harish Krishnaswamy

Senior Vice President of Business Development & Portfolio Planning

FAQs

What is MacroGenics Inc. share price today?

MacroGenics Inc. share price today is $3.70 as on at the close of the market. MacroGenics Inc. share today touched a day high of $4.05 and a low of $3.36.

What is the 52 week high and 52 week low for MacroGenics Inc. share?

MacroGenics Inc. share touched a 52 week high of $5.08 on and a 52 week low of $1.29 on . MacroGenics Inc. stock price today i.e. is closed at $3.70,which is 27.17% down from its 52 week high and 186.82% up from its 52 week low.

What is MacroGenics Inc.'s market capitalisation today?

MacroGenics Inc. market capitalisation is $0.00T as on .

How to invest in MacroGenics Inc. Stock (MGNX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for MacroGenics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MacroGenics Inc. Shares that will get you 0.4054 shares as per MacroGenics Inc. share price of $3.70 per share as on July 25, 2026 at 8:45 am IST.

What is the minimum amount required to buy MacroGenics Inc. Stock (MGNX) from India?

Indian investors can start investing in MacroGenics Inc. (MGNX) shares with as little as ₹96.56 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹965.60 in MacroGenics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on MacroGenics Inc. share’s latest price of $3.70 as on July 25, 2026 at 8:45 am IST, you will get 2.7027 shares of MacroGenics Inc.. Learn more about fractional shares .

What are the returns that MacroGenics Inc. has given to Indian investors in the last 5 years?

MacroGenics Inc. stock has given -85.45% share price returns and 29.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?